Valeant, Pershing Square get to vote at Allergan shareholder meeting
This article was originally published in Scrip
Executive Summary
A federal judge in California has determined that Allergan's largest shareholder Pershing Square Capital Management and Valeant Pharmaceuticals can participate in Allergan's 18 December special shareholder meeting if they comply with certain disclosure requirements; Allergan vowed to file an emergency appeal.